Clinical Trial Update: Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in children evaluates solifenacin, mirabegron, and their combination for daytime urinary incontinence; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence in Children

Drugs mentioned

• Mirabegron (mirabegron)
• Solifenacin (solifenacin)

Snippet

Sponsor: University of Aarhus | Conditions: Urinary Incontinence in Children | Phase 3 | Status: RECRUITING